Acadia Price To Sales Ratio vs Ev To Sales Analysis

ACHC Stock

USD 40.63 0.65 1.57%

Acadia Healthcare financial indicator trend analysis is way more than just evaluating Acadia Healthcare prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Acadia Healthcare is a good investment. Please check the relationship between Acadia Healthcare Price To Sales Ratio and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Acadia Healthcare Price To Sales Ratio account and Ev To Sales. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Acadia Healthcare's Price To Sales Ratio and Ev To Sales is 0.89. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Acadia Healthcare, assuming nothing else is changed. The correlation between historical values of Acadia Healthcare's Price To Sales Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Acadia Healthcare are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Price To Sales Ratio i.e., Acadia Healthcare's Price To Sales Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Acadia Healthcare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Acadia Healthcare sales, a figure that is much harder to manipulate than other Acadia Healthcare multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Acadia Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Acadia Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.At present, Acadia Healthcare's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 47.10, whereas Selling General Administrative is forecasted to decline to about 174.7 M.

	2021	2022	2023	2024 (projected)
Interest Expense	77.0M	69.8M	82.1M	106.0M
Depreciation And Amortization	106.7M	117.8M	132.3M	92.7M

Interest Expense Depreciation And Amortization

Acadia Healthcare fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Good Will	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables
Common Stock Shares Outstanding		0.94	0.56	0.62	0.96	0.93	0.92	0.43	0.95	-0.22	0.27	0.84	0.94	0.99	0.89	0.78	0.21	0.87	0.78	0.35	0.92	0.88	0.79	0.77	0.36	0.94
Total Assets	0.94		0.56	0.66	0.93	0.96	0.89	0.47	0.97	-0.38	0.34	0.96	0.98	0.95	0.95	0.93	0.07	0.94	0.92	0.43	0.97	0.8	0.81	0.91	0.41	0.91
Other Current Liab	0.56	0.56		0.98	0.51	0.52	0.54	0.8	0.46	-0.25	0.68	0.54	0.46	0.59	0.35	0.42	0.48	0.36	0.37	-0.3	0.42	0.65	0.74	0.38	0.79	0.61
Total Current Liabilities	0.62	0.66	0.98		0.57	0.58	0.62	0.79	0.55	-0.28	0.7	0.66	0.55	0.65	0.45	0.55	0.37	0.46	0.5	-0.19	0.52	0.64	0.8	0.52	0.77	0.67
Total Stockholder Equity	0.96	0.93	0.51	0.57		0.96	0.95	0.33	0.95	-0.38	0.13	0.79	0.96	0.96	0.92	0.74	0.32	0.9	0.74	0.45	0.94	0.88	0.71	0.72	0.27	0.97
Other Liab	0.93	0.96	0.52	0.58	0.96		0.9	0.35	0.96	-0.45	0.19	0.87	0.98	0.93	0.95	0.84	0.18	0.94	0.83	0.47	0.96	0.85	0.75	0.82	0.29	0.94
Accounts Payable	0.92	0.89	0.54	0.62	0.95	0.9		0.3	0.89	-0.3	0.12	0.77	0.9	0.92	0.89	0.71	0.35	0.88	0.71	0.46	0.9	0.85	0.68	0.68	0.24	0.99
Cash	0.43	0.47	0.8	0.79	0.33	0.35	0.3		0.31	-0.12	0.9	0.53	0.31	0.45	0.2	0.41	0.15	0.22	0.34	-0.49	0.26	0.49	0.68	0.36	0.99	0.36
Good Will	0.95	0.97	0.46	0.55	0.95	0.96	0.89	0.31		-0.39	0.19	0.9	0.98	0.95	0.95	0.88	0.06	0.93	0.88	0.5	0.98	0.76	0.76	0.87	0.24	0.91
Inventory	-0.22	-0.38	-0.25	-0.28	-0.38	-0.45	-0.3	-0.12	-0.39		-0.13	-0.34	-0.46	-0.22	-0.35	-0.36	-0.03	-0.36	-0.35	-0.08	-0.39	-0.18	-0.34	-0.35	-0.18	-0.38
Other Current Assets	0.27	0.34	0.68	0.7	0.13	0.19	0.12	0.9	0.19	-0.13		0.46	0.18	0.26	0.05	0.36	-0.16	0.06	0.3	-0.55	0.12	0.22	0.64	0.35	0.91	0.17
Total Liab	0.84	0.96	0.54	0.66	0.79	0.87	0.77	0.53	0.9	-0.34	0.46		0.9	0.85	0.88	0.98	-0.12	0.89	0.97	0.38	0.91	0.67	0.81	0.97	0.47	0.79
Intangible Assets	0.94	0.98	0.46	0.55	0.96	0.98	0.9	0.31	0.98	-0.46	0.18	0.9		0.93	0.97	0.89	0.11	0.96	0.89	0.51	0.99	0.8	0.74	0.88	0.26	0.93
Common Stock	0.99	0.95	0.59	0.65	0.96	0.93	0.92	0.45	0.95	-0.22	0.26	0.85	0.93		0.89	0.79	0.24	0.87	0.78	0.35	0.92	0.89	0.8	0.77	0.36	0.94
Property Plant Equipment	0.89	0.95	0.35	0.45	0.92	0.95	0.89	0.2	0.95	-0.35	0.05	0.88	0.97	0.89		0.89	0.09	0.99	0.9	0.66	0.99	0.77	0.64	0.88	0.14	0.9
Short Long Term Debt Total	0.78	0.93	0.42	0.55	0.74	0.84	0.71	0.41	0.88	-0.36	0.36	0.98	0.89	0.79	0.89		-0.2	0.9	1.0	0.48	0.91	0.59	0.72	0.99	0.36	0.72
Net Tangible Assets	0.21	0.07	0.48	0.37	0.32	0.18	0.35	0.15	0.06	-0.03	-0.16	-0.12	0.11	0.24	0.09	-0.2		0.11	-0.21	-0.07	0.09	0.51	0.05	-0.25	0.15	0.38
Property Plant And Equipment Net	0.87	0.94	0.36	0.46	0.9	0.94	0.88	0.22	0.93	-0.36	0.06	0.89	0.96	0.87	0.99	0.9	0.11		0.91	0.66	0.99	0.76	0.62	0.88	0.17	0.89
Net Debt	0.78	0.92	0.37	0.5	0.74	0.83	0.71	0.34	0.88	-0.35	0.3	0.97	0.89	0.78	0.9	1.0	-0.21	0.91		0.53	0.91	0.57	0.69	0.99	0.3	0.72
Retained Earnings	0.35	0.43	-0.3	-0.19	0.45	0.47	0.46	-0.49	0.5	-0.08	-0.55	0.38	0.51	0.35	0.66	0.48	-0.07	0.66	0.53		0.6	0.19	-0.07	0.49	-0.53	0.41
Non Current Assets Total	0.92	0.97	0.42	0.52	0.94	0.96	0.9	0.26	0.98	-0.39	0.12	0.91	0.99	0.92	0.99	0.91	0.09	0.99	0.91	0.6		0.78	0.7	0.89	0.21	0.91
Non Currrent Assets Other	0.88	0.8	0.65	0.64	0.88	0.85	0.85	0.49	0.76	-0.18	0.22	0.67	0.8	0.89	0.77	0.59	0.51	0.76	0.57	0.19	0.78		0.7	0.56	0.44	0.89
Other Assets	0.79	0.81	0.74	0.8	0.71	0.75	0.68	0.68	0.76	-0.34	0.64	0.81	0.74	0.8	0.64	0.72	0.05	0.62	0.69	-0.07	0.7	0.7		0.72	0.64	0.73
Long Term Debt	0.77	0.91	0.38	0.52	0.72	0.82	0.68	0.36	0.87	-0.35	0.35	0.97	0.88	0.77	0.88	0.99	-0.25	0.88	0.99	0.49	0.89	0.56	0.72		0.32	0.7
Cash And Short Term Investments	0.36	0.41	0.79	0.77	0.27	0.29	0.24	0.99	0.24	-0.18	0.91	0.47	0.26	0.36	0.14	0.36	0.15	0.17	0.3	-0.53	0.21	0.44	0.64	0.32		0.31
Net Receivables	0.94	0.91	0.61	0.67	0.97	0.94	0.99	0.36	0.91	-0.38	0.17	0.79	0.93	0.94	0.9	0.72	0.38	0.89	0.72	0.41	0.91	0.89	0.73	0.7	0.31

Click cells to compare fundamentals

Acadia Healthcare Account Relationship Matchups

Acadia Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	87.8M	88.6M	90.8M	91.6M	90.9M	68.4M
Total Assets	6.9B	6.5B	4.8B	5.0B	5.4B	4.4B
Other Current Liab	225.2M	956.7M	308.7M	319.5M	663.9M	697.1M
Total Current Liabilities	463.6M	1.3B	404.9M	388.3M	885.8M	930.1M
Total Stockholder Equity	2.5B	1.9B	2.5B	2.8B	2.8B	1.8B
Other Liab	225.7M	183.4M	184.9M	206.8M	237.8M	144.7M
Accounts Payable	127.0M	87.8M	98.6M	104.7M	156.1M	84.8M
Cash	124.2M	378.7M	133.8M	97.6M	100.1M	97.3M
Good Will	2.4B	2.1B	2.2B	2.2B	2.2B	1.8B
Inventory	4.8M	4.9M	4.8M	5.1M	5.3M	5.6M
Other Current Assets	78.2M	1.9B	75.1M	81.0M	61.1M	58.0M
Total Liab	4.4B	4.6B	2.2B	2.1B	2.5B	2.6B
Intangible Assets	90.4M	68.5M	70.1M	76.0M	73.3M	60.8M
Common Stock	877K	880K	890K	899K	913K	777.4K
Property Plant Equipment	3.2B	1.6B	1.9B	2.1B	2.4B	1.8B
Short Long Term Debt Total	3.7B	3.2B	1.6B	1.5B	1.5B	2.2B
Net Tangible Assets	(956K)	(219.0M)	247.4M	513.9M	591.0M	620.5M
Property Plant And Equipment Net	3.7B	1.7B	1.9B	2.1B	2.4B	2.0B
Net Debt	3.6B	2.8B	1.5B	1.4B	1.4B	2.1B
Retained Earnings	361.7M	(310.4M)	(119.8M)	153.4M	131.7M	117.6M
Non Current Assets Total	6.3B	4.0B	4.3B	4.5B	4.8B	4.2B
Non Currrent Assets Other	62.7M	58.7M	67.9M	65.1M	72.6M	53.4M
Other Assets	71.6M	179.3M	98.0M	95.6M	110.0M	91.0M
Long Term Debt	3.1B	3.0B	1.5B	1.4B	1.3B	2.1B
Cash And Short Term Investments	124.2M	378.7M	133.8M	97.6M	100.1M	104.0M
Net Receivables	339.8M	273.6M	281.3M	322.4M	429.5M	258.5M
Common Stock Total Equity	874K	877K	880K	890K	1.0M	787.9K
Retained Earnings Total Equity	252.8M	361.7M	(310.4M)	(119.8M)	(107.8M)	(102.4M)
Long Term Debt Total	3.2B	3.1B	3.0B	1.5B	1.7B	2.3B
Liabilities And Stockholders Equity	6.9B	6.5B	4.8B	5.0B	5.4B	4.8B
Non Current Liabilities Total	3.9B	3.3B	1.8B	1.7B	1.6B	2.3B
Capital Surpluse	2.5B	2.6B	2.6B	2.6B	3.0B	2.0B
Other Stockholder Equity	2.6B	2.6B	2.6B	2.7B	2.6B	2.0B
Deferred Long Term Liab	80.4M	140.8M	50.0M	74.4M	85.5M	60.0M
Property Plant And Equipment Gross	3.2B	1.7B	1.9B	2.1B	3.2B	2.1B
Total Current Assets	542.2M	2.5B	495.0M	506.1M	596M	590.6M
Non Current Liabilities Other	630.8M	217.4M	227.3M	125.0M	140.1M	180.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Acadia Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Acadia Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Acadia Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Acadia Healthcare Stock:

How To Invest In Acadia

Details

Is Acadia Stock a good investment?

Details

What is Acadia Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acadia Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For information on how to trade Acadia Stock refer to our How to Trade Acadia Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acadia Healthcare. If investors know Acadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acadia Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.076

Earnings Share

3.05

Revenue Per Share

34.13

Quarterly Revenue Growth

0.087

Return On Assets

0.0606

The market value of Acadia Healthcare is measured differently than its book value, which is the value of Acadia that is recorded on the company's balance sheet. Investors also form their own opinion of Acadia Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Acadia Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acadia Healthcare's market value can be influenced by many factors that don't directly affect Acadia Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Acadia Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acadia Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acadia Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Acadia Price To Sales Ratio vs Ev To Sales Analysis

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Ev To Sales

Acadia Healthcare fundamental ratios Correlations

Acadia Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Acadia Healthcare fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Common Stock	+ 0.99	Common Stock Shares Outstanding
Net Receivables	+ 0.99	Accounts Payable
Cash And Short Term Investments	+ 0.99	Cash
Non Current Assets Total	+ 0.99	Intangible Assets
Property Plant And Equipment Net	+ 0.99	Property Plant Equipment

Retained Earnings	- 0.55	Other Current Assets
Cash And Short Term Investments	- 0.53	Retained Earnings
Retained Earnings	- 0.49	Cash
Intangible Assets	- 0.46	Inventory
Inventory	- 0.45	Other Liab
Non Current Assets Total	- 0.39	Inventory